Related Experiment Video
Updated: Apr 19, 2026

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
Published on: November 7, 2018
Global invasive bacterial vaccine-preventable diseases surveillance--2008-2014
Insights
Pneumococcal conjugate vaccines (PCV) significantly reduce childhood meningitis and pneumonia deaths. Global introduction of PCV is ongoing, with surveillance guiding its impact and implementation for child health.
Area of Science:
- Pediatrics
- Infectious Diseases
- Vaccinology
Background:
- Meningitis and pneumonia caused by Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae are major global child health threats.
- Streptococcus pneumoniae was a leading cause of death in children under five before the introduction of pneumococcal conjugate vaccines (PCV).
Purpose of the Study:
- To highlight the global impact of PCV on reducing childhood morbidity and mortality.
- To emphasize the importance of surveillance in guiding PCV introduction and monitoring its effectiveness.
Main Methods:
- Review of global health data concerning childhood infections and vaccine introduction.
- Analysis of World Health Organization (WHO) and Gavi, the Vaccine Alliance recommendations and implementation data.
Main Results:
- PCV is recommended by the WHO for global childhood immunization programs, particularly in high child mortality regions.
- As of November 2014, 58% of WHO member states had introduced PCV.
- Invasive pneumococcal disease (IPD) and syndromic surveillance are crucial for informing PCV policy and assessing impact.
Conclusions:
- PCV introduction is critical for reducing the burden of pneumococcal disease in children worldwide.
- Continued surveillance is essential for optimizing PCV strategies and maximizing public health benefits.
Abstract:
Meningitis and pneumonia are leading causes of morbidity and mortality in children globally infected with Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis, and Haemophilus influenzae causing a large proportion of disease. Vaccines are available to prevent many of the common types of these infections. S. pneumoniae was estimated to have caused 11% of deaths in children aged <5 years globally in the pre-pneumococcal conjugate vaccine (PCV) era. Since 2007, the World Health Organization (WHO) has recommended inclusion of PCV in childhood immunization programs worldwide, especially in countries with high child mortality. As of November 26, 2014, a total of 112 (58%) of all 194 WHO member states and 44 (58%) of the 76 member states ever eligible for support from Gavi, the Vaccine Alliance (Gavi), have introduced PCV. Invasive pneumococcal disease (IPD) surveillance that includes data on serotypes, along with meningitis and pneumonia syndromic surveillance, provides important data to guide decisions to introduce PCV and monitor its impact.
More Related Videos
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Related Concept Videos
Principles of Disease Surveillance
Vaccinations
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Infectious Diseases and Their Occurrence
Bacterial Gastroenteritis
Investigation of Disease Outbreaks